Equity Offerings, Offering Expenses, and Distributions - Schedule of Outstanding Preferred Shares Activity (Details) - shares	3 Months Ended
	Sep. 30, 2022		Sep. 30, 2021
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance, Preferred Stock Classified as Temporary Equity (in shares)	29,607,882	[1]	0
Shares Issued (in shares)	11,521,659		8,805,451
Shares issued through Preferred Stock DRIP (in shares)	9,395		1,642
Shares Converted to Common (in shares)	(274,644)		(2,150)
Ending balance, Preferred Stock Classified as Temporary Equity (in shares)	40,864,292		14,601,471	[1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares outstanding, Beginning balance (in shares)			5,481,592
Stock Issued (in shares)			9,120,074
Shares issued through Preferred Stock DRIP (in shares)			1,955
Shares Converted to Common (in shares)			(2,150)
Shares outstanding, Ending balance (in shares)			14,601,471
Series A1
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance, Preferred Stock Classified as Temporary Equity (in shares)	20,794,645
Shares Issued (in shares)	10,157,297
Shares issued through Preferred Stock DRIP (in shares)	9,183
Shares Converted to Common (in shares)	(209,163)
Ending balance, Preferred Stock Classified as Temporary Equity (in shares)	30,751,961
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares outstanding, Beginning balance (in shares)			5,163,926
Stock Issued (in shares)			2,946,568
Shares issued through Preferred Stock DRIP (in shares)			1,907
Shares Converted to Common (in shares)			(2,150)
Shares outstanding, Ending balance (in shares)			8,110,251
Series M1
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance, Preferred Stock Classified as Temporary Equity (in shares)	2,626,238
Shares Issued (in shares)	1,364,362
Shares issued through Preferred Stock DRIP (in shares)	212
Shares Converted to Common (in shares)	(65,481)
Ending balance, Preferred Stock Classified as Temporary Equity (in shares)	3,925,331
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares outstanding, Beginning balance (in shares)			130,666
Stock Issued (in shares)			173,506
Shares issued through Preferred Stock DRIP (in shares)			48
Shares Converted to Common (in shares)			0
Shares outstanding, Ending balance (in shares)			304,220
Series A2
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance, Preferred Stock Classified as Temporary Equity (in shares)	187,000
Shares Issued (in shares)	0
Shares issued through Preferred Stock DRIP (in shares)	0
Shares Converted to Common (in shares)	0
Ending balance, Preferred Stock Classified as Temporary Equity (in shares)	187,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares outstanding, Beginning balance (in shares)			187,000
Stock Issued (in shares)			0
Shares issued through Preferred Stock DRIP (in shares)			0
Shares Converted to Common (in shares)			0
Shares outstanding, Ending balance (in shares)			187,000
Series A
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance, Preferred Stock Classified as Temporary Equity (in shares)	6,000,000
Shares Issued (in shares)	0
Shares issued through Preferred Stock DRIP (in shares)	0
Shares Converted to Common (in shares)	0
Ending balance, Preferred Stock Classified as Temporary Equity (in shares)	6,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares outstanding, Beginning balance (in shares)			0
Stock Issued (in shares)			6,000,000
Shares issued through Preferred Stock DRIP (in shares)			0
Shares Converted to Common (in shares)			0
Shares outstanding, Ending balance (in shares)			6,000,000

[1] Certain reclassifications have been made in the presentation of prior year amounts since initial disclosure in our Quarterly Report on Form 10-Q for the period ended September 30, 2021 to conform to the presentation in our Annual Report on Form 10-K for the year ended June 30, 2022. In addition, we have not yet finalized return of capital estimates for the current period. See Note 2 and Note 12 within the accompanying notes to consolidated financial statements for further discussion.